Hjem › Plateepitelcancer i hode og hals › District of Columbia
Kliniske studier for Plateepitelcancer i hode og hals i District of Columbia
9 studier for Plateepitelcancer i hode og hals søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- George Washington University Cancer Center, Washington D.C.
RekruttererFase 3
Alder 60 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04892173Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- MedStar Washington Hospital Center, Washington D.C.
RekruttererFase 2
Alder 18 til 79 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05983432Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- George Washington University Medical Center, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Washington D.C.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07182149Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- George Washington University Medical Center, Washington D.C.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06532279A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 26. mai 2026 · NCT06256588A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- The George Washington University, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06064877VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
RekruttererFase 1/2
Alder 18 til 80 · Alle kjønn · Oppdatert 11. des. 2025 · NCT03556228Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.